Skip to Content

Corteva Inc

CTVA: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$12.00BqnJfxhcwqm

Corteva Earnings: Inventory Reset Weighs on Crop Protection Profits

Corteva's detailed third-quarter results confirm our initial view that the company is likely to face a continued profit decline in 2023 due to an industrywide crop chemicals inventory reset. The company had released preliminary revised earnings expectations in late October. With our outlook unchanged, we maintain our $67 fair value estimate and wide moat rating.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CTVA so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center